Article Per Year (5 Year)
p-Index From 2020 - 2025
0.408
P-Index
This Author published in this journals
All Journal KESANS : International Journal of Health and Science
Costa Monteiro, Ermelinda da
Unknown Affiliation
Chemistry Health Professions Medicine & Pharmacology Physics Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Factors That Influence the Visits of The Fourth Trimester (K4) For Pregnancy at the Soibada Health Center, Soibada Administrative Post, Manatuto Municipality, Timor-Leste, 2023 Carvalho de Araujo, Eugenia; Costa Monteiro, Ermelinda da; Jose Soares Tilman, Etelvina; Pereira, Natalia; Barreto Amaral, Meriana; Costa Soares, Lorena da
Jurnal KESANS : Kesehatan dan Sains Vol 3 No 6 (2024): KESANS: International Journal of Health and Science
Publisher : Rifa'Institute

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.54543/kesans.v3i6.283

Abstract

Introduction: The pregnancy is a natural process that occurs in women with reproductive age; for the pregnant to occur, it requires a process that meets the egg cell and spermatozoon when having sexual intercourse during ovulation. According to the Timor Leste Health Demographic Survey 2016, the maternal mortality rate is 218/100,000 live births. The Ministry of Health data showed that K1 and K4 visits reached 80 90%. The report from the Ministry of Health in 2022 revealed that the initial pregnant mother visits (K1) in the center reached 39,608 (79%), and K4 visits reached 26,567 (53%). The Soibada Health Center report in 2020 showed that the initial pregnant mother visits (K1) total of 1931 (71%) and K4 visits with a total of 1415 (52%). Objective: To determine the factors that influence the visits of the fourth trimester (K4) for pregnancy at the Soibada Health Center, Soibada Administrative Post, Manatuto Municipality, Timor Leste in the year 2023. Method: This research used quantitative analytical methods with a cross sectional approach. The population for this research is the pregnancy who visit the Soibada Health Center, Soibada Administrative Post. Result and Discussion: The respondents for this research were 88, with the following results: 36 (40.9%) had a primary education level, 46 (52.3%) were aged <20 or >35, 54 (61.4%) did not work together, 48 (54.5%) were Mult pregnancy, 47 (53.4%) had less knowledge, and there were 52 (59.1%) irregular visits to the clinic. Conclusion: Based on this research, we conclude that factors such as education level, age, occupation, parity, and knowledge influence irregular visits to the clinic. Therefore, we urge health personnel to pay more attention to these factors, especially in terms of consulting standards for women's health.
Difference in Secondary Effects Between AstraZeneca Vaccine and Sinovac Vaccine for Females Aged 18 and above in 2023 Costa Monteiro, Ermelinda da; Costa Neto, Sandra da; Dionisio Ximenes, Jose; Conceição Matos, Livio da; Carvalho de Araújo, Eugenia; Soares Tilman, Etelvina Jose
Jurnal KESANS : Kesehatan dan Sains Vol 3 No 7 (2024): KESANS: International Journal of Health and Science
Publisher : Rifa'Institute

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.54543/kesans.v3i7.289

Abstract

Introduction: The COVID-19 pandemic has had a severe impact on health, economy, and society worldwide. According to WHO, COVID-19 vaccines are safe and effective in protecting individuals from the risk of severe COVID-19 disease and death. COVID-19 vaccines have received   Emergency Use Listing (EUL) and Emergency Use Authorization (EUA) licenses. According World in Data, 53.8% of the global population has received the first dose of COVID-19 vaccination, with 7 million doses provided globally. Timor Leste has vaccine coverage of 78% and 65.1% for the first and second doses of AstraZeneca and 6.3% and 5.9% for Sinovac. Objective: To determine the difference in the secondary effects of AstraZeneca and Sinovac vaccines for females aged 18 or older in Becora village, Cristo Rei administrative post, Dili municipality, in the year 2023. Method: A quantitative analytical method with a cross sectional approach was used with a total sample population of 325 female respondents aged 18 or older who had received the AstraZeneca or Sinovac vaccines. Results and Discussion: Out of the 325 female respondents, 173 (53.2%) received the AstraZeneca vaccine, and 152 (46.8%) received the Sinovac vaccine. 142 (82.1%) of the AstraZeneca vaccine recipients and 92 (60.5%) of the Sinovac vaccine recipients experienced side effects classified as mild. 89 (51.4%) of the AstraZeneca vaccine recipients reported lower body pain. The Sinovac vaccine accounts for 44 (28.9%) of the total. The statistical test results show that there is a significant difference in secondary effects between the AstraZeneca and Sinovac vaccines (p value: 0.000) in cotton thread. The secondary effects in the body are different between the AstraZeneca and Sinovac vaccines (p value: 0.000). Conclusion: Based on the results from female respondents aged 18 and above who have received COVID-19 vaccines, it shows that there is a difference in secondary effects between the AstraZeneca and Sinovac vaccines.
Co-Authors Barreto Amaral, Meriana Carvalho de Araujo, Eugenia Conceição Matos, Livio da Costa Neto, Sandra da Costa Soares, Lorena da Dionisio Ximenes, Jose Jose Soares Tilman, Etelvina Pereira, Natalia Soares Tilman, Etelvina Jose